Rapid and sensitive detection of internal tandem duplication and activating loop mutations of FLT3

British Journal of Haematology

Volumn 130, Issue 2, 2005, Pages 203-208

  Mills, Ken I ^a   Gilkes, Amanda F ^a   Walsh, Val ^a   Sweeney, Marion ^a   Gale, Rosemary ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Activating loop mutations; Acute myeloid leukaemia; Bioanalyser; FLT3 mutations; Internal tandem duplication

Indexed keywords

FLT3 LIGAND; CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TANDEM REPEAT; ACUTE DISEASE; AGE DISTRIBUTION; EVALUATION; GENETICS; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; SEX RATIO;

ACUTE DISEASE; AGE DISTRIBUTION; BASE SEQUENCE; FEMALE; FMS-LIKE TYROSINE KINASE 3; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SEX DISTRIBUTION; TANDEM REPEAT SEQUENCES; TUMOR MARKERS, BIOLOGICAL;

EID: 24944590535     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05589.x     Document Type: Article

References (19)

1. Abu-Duhier, F.M., Goodeve, A.C., Wilson, G.A., Gari, M.A., Peake, I.R., Rees, D.C., Vandenberghe, E.A., Winship, P.R. & Reilly, J.T. (2000) FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. British Journal of Haematology, 111, 190-195.
2. Bianchini, M., Ottaviani, E., Grafone, T., Giannini, B., Soverini, S., Terragna, C., Amabile, M., Piccaluga, P.P., Malagola, M., Rondoni, M., Bosi, C., Baccarani, M. & Martinelli, G. (2003) Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC. Clinical Chemistry, 49, 1642-1650.
3. Boissel, N., Cayuela, J.M., Preudhomme, C., Thomas, X., Grardel, N., Fund, X., Tigaud, I., Raffoux, E., Rousselot, P., Sigaux, F., Degos, L., Castaigne, S., Fenaux, P. & Dombret, H. (2002) Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy. Leukemia, 16, 1699-1704.
4. Care, R.S., Valk, P.J., Goodeve, A.C., Abu-Duhier, P.M., Geertsma-Kleinekoort, W.M., Wilson, G.A., Gari, M.A., Peake, I.R., Lowenberg, B. & Reilly, J.T. (2003) Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias. British Journal of Haematology, 121, 775-777.
5. Frohling, S., Schlenk, R.F., Breitruck, J., Benner, A., Kreitmeier, S., Tobis, K., Dohner, H. & Dohner, K. (2002) Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. Blood, 100, 4372-4380.
6. Griffin, J.D. (2001) Point mutations in the FLT3 gene in AML. Blood, 97, 2193A-22193.
7. Kindler, T., Breitenbuecher, F., Kasper, S., Estey, E., Giles, F., Feldman, E., Ehninger, G., Schiller, G., Klimek, V., Nimer, S.D., Gratwohl, A., Choudhary, C., Mueller-Tidow, C., Serve, H., Gschaidmeier, H., Cohen, P.S., Huber, C. & Fischer, T. (2005) Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML). Blood, 105, 335-340.
8. Kottaridis, P.D., Gale, R.E., Frew, M.E., Harrison, G., Langabeer, S.E., Belton, A.A., Walker, H., Wheatley, K., Bowen, D.I., Burnett, A.K., Goldstone, A.H. & Linch, D.C. (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood, 98, 1752-1759.
9. Kottaridis, P.D., Gale, R.E., Langabeer, S.E., Frew, M.E., Bowen, D.T. & Linch, D.C. (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. Blood, 100, 2393-2398.
10. Meshinchi, S., Woods, W.G., Stirewalt, D.L., Sweetser, D.A., Buckley, J.D., Tjoa, T.K., Bernstein, I.D. & Radich, J.P. (2001) Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood, 97, 89-94.
11. Moreno, I., Martin, G., Bolufer, P., Barragan, E., Rueda, E., Roman, J., Fernandez, P., Leon, P., Mena, A., Cervera, J., Torres, A. & Sanz, M.A. (2003) Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. Haematologica, 88, 19-24.
12. Noguera, N.I., Breccia, M., Divona, M., Diverio, D., Costa, V., De Santis, S., Avvisati, G., Pinazzi, M.B., Petti, M.C., Mandelli, F. & Lo Coco, F. (2002) Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia, 16, 2185-2189.
13. Panaro, N.J., Yuen, P.K., Sakazume, T., Fortina, P., Kricka, L.J. & Wilding, P. (2000) Evaluation of DNA fragment sizing and quantification by the Agilent 2100 Bioanalyzer. Clinical Chemistry, 46, 1851-1853.
14. Piccaluga, P.P., Bianchini, M. & Martinelli, G. (2003) Novel FLT3 point mutation in acute myeloid leukaemia. Lancet Oncology, 4, 604.
15. Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., Loffler, H., Sauerland, C.M., Serve, H., Buchner, T., Haferlach, T. & Hiddemann, W. (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 100, 59-66.
16. Spiekermann, K., Bagrintseva, K., Schoch, C., Haferlach, T., Hiddemann, W. & Schnittger, S. (2002) A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia. Blood, 100, 3423-3425.
17. Stirewalt, D.L., Meshinchi, S., Kussick, S.J., Sheets, K.M., Pogosova-Agadjanyan, E., Willman, C.L. & Radich, J.P. (2004) Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia. British Journal of Haematology, 124, 481-484.
18. Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schakel, U., Platzbecker, U., Wermke, M., Bornhauser, M., Ritter, M., Neubauer, A., Ehninger, G. & Illmer, T. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 99, 4326-4335.
19. Vaughn, C.P. & Elenitoba-Johnson, K.S. (2004) High-resolution melting analysis for detection of internal tandem duplications. Journal of Molecular Diagnostics, 6, 211-216.